Dissertation > Excellent graduate degree dissertation topics show

The Expression of p53 Gene in the Rats Spinal Cord Induced by Combined Treatment with Cisplatin and/or Docetaxel and Radiation

Author: Yu
Tutor: ShaoShuJuan
School: Dalian Medical University
Course: Human Anatomy and Embryology
Keywords: spinal cord injury chemotherapy radiotherapy p53
CLC: R730.5
Type: Master's thesis
Year: 2006
Downloads: 35
Quote: 0
Read: Download Dissertation

Abstract


Objective: P53 gene involves in cell cycle regulation. In the normal conditions, the p53 protein exists by the low concentration in the body tissue. When the point mutation, loss and inactivation occurring to p53 gene, through the molecular examination method, may detect the abnormal expression of the p53 protein. At present the association of chemotherapy (CT) and radiotherapy (RT) has been applied widely for the treatment of carcinoma. When the tissues receive the ionization radiation, the chemotherapy medicine and so on should stir up the injury, then p53 is activated and the maintenant the stable expression, which displaying the cell cycle monitoring, promoting the apoptosis of the cells, and guarding against the canceration[1]. Although the combination of CT and RT has obvious improvement on the local control rate, comparing to the single treatment, it increases the toxic effect on the critical normal tissues, inducing various complications. Especially, during the carcinoma therapy involving organs such as head/neck, esophagus, phinophargnx cancer, lung and spinal column, the spinal cord has been irradiated inevitably for a higher dose, even nearing its tolerance. The data of spinal cord injury induced by chemoradiotherapy is quite scarce, because as a late phase injury with manifestation appeared several months or years after the therapy. In this experiment, the spinal cord injury model was established on rats through imitating clinical chemoradiotherapy. Then we observed whether combination of cisplatin/docetaxel and radiotherapy would deteriorate the injury on spinal cord. Determines the expressions of p53 through immunohistochemistry, thus discuss the influence of

Related Dissertations

  1. The Regulate and Controlof Slug on P53-MDM2 System,R730.2
  2. Study the Protective Value of Spect Lung Perfusion to Lung Function in Esophageal Cancer Patients Treated with Radiotherapy,R735.1
  3. A Feasibility Study of IMRT Dosimetric Verification Using Radiochromic Film,R815
  4. The Clinical Study of Cone-beam CT Combining with Active Breathing Control System on Lung Cancer Radiotherapy,R734.2
  5. Study of Sepia Ink-Astragalus Preparation for Relieving Damage Caused by Chemotherapy,R285.5
  6. Yu Ren- Cun Academic Thought and clinical experience in the clinical observation of combination chemotherapy in advanced gastric cancer with Yiqihuoxuejiedu side,R249
  7. Research of Screening and Function of P53 Regulators in KZNF (AxZ Type、SABZ Type and ACxZ Type) Family,R730.2
  8. Anesthesia Management of Cervical Spinal Cord Injury,R614
  9. Inhibition of Conventional Chemotherapy Combined with Metronomic Chemotherapy on Breast Cancer Xenografts in Nude Mice,R737.9
  10. Comparative Analysis on CTF and CEF Regimens as Postoperative Adjuvant Chemotherapy in the Treatment of Phase Ⅱ Breast Cancer,R737.9
  11. Effects on Telomere Length of Epithelial Ovarian Cancer by Chemotherapy,R737.31
  12. Recurrent Ovarian Cancer Surgery Again with Surial Analysis of Relevant Factors,R737.31
  13. Clinical Observation of Pemetrexed for Treating Advanced Non-small Cell Lung Cancer,R734.2
  14. Study of MRI Diffusion-weighted Imaging in the Diagnosis of Lymphadenopathy and Evaluation after Radiotherapy,R445.2
  15. Experimental Investigation of Grafting Pathways of Bone Marrow Stromal Cells into Spinal Cord Injury in Rats.,R651.2
  16. The Experimental Study of Antiangiogenic and Induction of Apoptosis by Maximum Tolerated Dose Combined with Low-dose Cyclophosphamide in Breast Cancer,R737.9
  17. Maximum Tolerated Dose Combined with Metronomic Chemoterpy on Proliferation and Angiogenesis in Treatment of Breast Cancer,R737.9
  18. The Shrink Pattern of Breast Cancer After Neoadjuvant Chemotherapy and the Correlation with Partial Clinic Pathological Factors: Preliminary Results of a Plot Study,R737.9
  19. The Relationship between CEF/TE Neo-adjuvant Chemotherapy, MAPK/PI3K Signal Pathway and Ki-67 in Breast Cancer,R737.9
  20. The Expression of PI3K and P53 in Prostate Cancer and Its Clinical Significance,R737.25
  21. Protein Expressions of EGFR、K-ras、P53 and Ki-67 in Colorectal Cancer, Gastric Cancer and Esophageal Cancer,R735

CLC: > Medicine, health > Oncology > General issues > Tumor Therapy
© 2012 www.DissertationTopic.Net  Mobile